Clinical Trial Update: Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether magnesium supplementation reduces implantable cardioverter-defibrillator shocks and improves quality of life in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia
• Hypomagnesemia

Drugs mentioned

• Magnesium (magnesium)

Snippet

Sponsor: Hartford Hospital | Conditions: Arrhythmia, Quality of Life | Phase 4 | Status: UNKNOWN